Home » Seed Banks » Serious Seeds » Serious Seeds CBD Chronic Feminized

Serious Seeds CBD Chronic Feminized
Sex Feminized
Autoflower
Indica/Sativa Sativa/Indica
Hybrid
Indoor Flowering 8-9 weeks
Yield Medium
Height Medium
THC Low
Outdoor Harvest October
Special Features Medical Strain
Beginner Strain
Top Genetics
Colours
Effect Narcotic
CBD High
Flavour
Grow Indoor/Outdoor

Serious Seeds CBD Chronic Feminized

Our biggest yielder Chronic was crossed with Remedy, a strain with extremely high CBD-content, in a collaboration with the CBD-Crew.

6 FEM
Sensible Seeds Price: $75.71

In Stock

Our price $75.71


Add to Wish List

SKU AR-SSM-007F-6

Description

CBD Chronic Feminized Cannabis Seeds

CBD Chronic Feminized Cannabis Seeds by Serious Seeds: Serious Seeds biggest yielder Chronic was crossed with Remedy, a strain with extremely high CBD-content, in a collaboration with the CBD-Crew. The combination was lab-tested in Spain and ALL 10 samples had a 1:1 ratio of THC:CBD. The average potency was 5.4 % THC 5.8 % CBD, with the best plant scoring 7,88 % THC and 6,93 % CBD!

CBD-Chronic can produce top-yields of 600g/m2 and is easy to grow and clone. She grows a HUGE top-cola with little side-branching. This first purely medical CBD-strain of Serious Seeds is a milestone, which enables patients/caregivers to produce big amounts of medical cannabis containing high levels of CBD. The production of medical extracts (e.g. Rick Simpson Oil) and lotions, cremes or ointments is made much easier with this strain.

CBD-Chronic is a medical strain, which is very well suited to treat the symptoms of e.g. Multiple Sclerosis, Epilepsy, Tourette-syndrome, Glaucoma and Arthritis.

Features

Sex: Feminized

Type: F1 Hybrid Indica/Sativa Hybrid

Grow: Indoor/Outdoor

Flowering Time: 56 to 63 days

Outdoor Harvest: Mid-October

Yield: 350 to 600g/m2

Genetics: Chronic x Remedy

 
The website uses cookies to allow us to better understand how the site is used. By continuing to use this site, you consent to this policy. Click to learn more.